Kleiner H E, Vulimiri S V, Miller L, Johnson W H, Whitman C P, DiGiovanni J
University of Texas MD Anderson Cancer Center, Science Park-Research Division, Department of Carcinogenesis, PO Box 389, Smithville, TX 78957, USA.
Carcinogenesis. 2001 Jan;22(1):73-82. doi: 10.1093/carcin/22.1.73.
Several naturally occurring coumarins, to which humans are routinely exposed in the diet, were previously found to inhibit P450-mediated metabolism of benzo[a]pyrene (B[a]P) and 7,12-dimethylbenz[a]anthracene (DMBA) in vitro, block DNA adduct formation in mouse epidermis and inhibit skin tumor initiation by B[a]P and/or DMBA when applied topically to mice. The present study was designed to investigate the effects of two of these compounds, of the linear furanocoumarin type, when given orally (70 mg/kg per os, four successive daily doses), on P450 and glutathione S-transferase (GST) activities and DNA adduct formation by B[a]P and DMBA in various mouse tissues. Imperatorin and isopimpinellin significantly blocked ethoxyresorufin O-deethylase (EROD) and pentoxyresorufin O:-dealkylase (PROD) activities in epidermis at 1 and 24 h after oral dosing. Imperatorin and isopimpinellin modestly inhibited EROD activities in lung and forestomach at 1 h and significantly inhibited PROD activities in lung and forestomach at 1 h after the final oral dose. Twenty-four hours after the final oral dose of imperatorin or isopimpinellin EROD and PROD activities remained inhibited in epidermis and lung. However, forestomach P450 activity had returned to control levels. Interestingly, imperatorin and isopimpinellin treatment inhibited liver EROD activity at 1 h, had no effect on PROD activity at this time point, but elevated both these enzyme activities at 24 h. Elevated EROD and PROD activities coincided with elevated hepatic P450 content. Imperatorin and isopimpinellin treatment also increased liver cytosolic GST activity at both 1 and 24 h after the final oral dose by 1.6-fold compared with corn oil controls. Oral administration of imperatorin and isopimpinellin also had a protective effect against DNA adduct formation by B[a]P and DMBA. Imperatorin pretreatment decreased formation of DNA adducts by DMBA in forestomach. Pretreatment with isopimpinellin led to reduced DNA adduct levels in liver (B[a]P), lung (B[a]P) and mammary epithelial cells (DMBA). These results suggest that imperatorin and isopimpinellin may have potential chemopreventive effects when administered in the diet.
先前发现,人类日常饮食中经常接触的几种天然香豆素在体外可抑制细胞色素P450介导的苯并[a]芘(B[a]P)和7,12 - 二甲基苯并[a]蒽(DMBA)的代谢,阻止小鼠表皮中的DNA加合物形成,并且当局部应用于小鼠时可抑制B[a]P和/或DMBA引发的皮肤肿瘤。本研究旨在调查口服(70 mg/kg,每日连续四次给药)两种线性呋喃香豆素类化合物对各种小鼠组织中细胞色素P450和谷胱甘肽S - 转移酶(GST)活性以及B[a]P和DMBA诱导的DNA加合物形成的影响。口服给药后1小时和24小时,欧前胡素和异茴芹内酯可显著抑制表皮中的乙氧基异吩恶唑酮O - 脱乙基酶(EROD)和戊氧基异吩恶唑酮O - 脱烷基酶(PROD)活性。末次口服给药后1小时,欧前胡素和异茴芹内酯适度抑制肺和前胃中的EROD活性,并显著抑制肺和前胃中的PROD活性。末次口服欧前胡素或异茴芹内酯24小时后,表皮和肺中的EROD和PROD活性仍受到抑制。然而,前胃中的细胞色素P450活性已恢复到对照水平。有趣的是,欧前胡素和异茴芹内酯处理在1小时时抑制肝脏EROD活性,此时对PROD活性无影响,但在24小时时提高了这两种酶的活性。EROD和PROD活性的升高与肝脏细胞色素P450含量的升高一致。末次口服给药后1小时和24小时,欧前胡素和异茴芹内酯处理还使肝脏胞质GST活性比玉米油对照组提高了1.6倍。口服欧前胡素和异茴芹内酯对B[a]P和DMBA诱导的DNA加合物形成也有保护作用。欧前胡素预处理可减少前胃中DMBA诱导的DNA加合物形成。异茴芹内酯预处理可降低肝脏(B[a]P)、肺(B[a]P)和乳腺上皮细胞(DMBA)中的DNA加合物水平。这些结果表明,欧前胡素和异茴芹内酯在饮食中给药时可能具有潜在的化学预防作用。